Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Clanton

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Circulation Research|May 1, 1983
The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogsC B Huddleston, F M Lupinetti, K H Laws, et al.
Investigative Radiology|September 1, 1984
Paramagnetic NMR contrast agents. Development and evaluationV M Runge, J A Clanton, M A Foster, et al.
Life Sciences|January 1, 1991
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptorsR M Kessler, M S Ansari, D E Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamidesR M Kessler, M S Ansari, T de Paulis, et al.
European Journal of Pharmacology|November 13, 1992
Visualization of extrastriatal dopamine D2 receptors in the human brainR M Kessler, N S Mason, J R Votaw, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
Brain Research|April 23, 1993
Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epideprideR M Kessler, W O Whetsell, M S Ansari, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
Particulate oral NMR contrast agentsV M Runge, M A Foster, J A Clanton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligandJ R Votaw, M S Ansari, N S Mason, et al.
Life Sciences|January 1, 1993
High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brainR M Kessler, J R Votaw, D E Schmidt, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Circulation Research|May 1, 1983
The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogsC B Huddleston, F M Lupinetti, K H Laws, et al.
Investigative Radiology|September 1, 1984
Paramagnetic NMR contrast agents. Development and evaluationV M Runge, J A Clanton, M A Foster, et al.
Life Sciences|January 1, 1991
High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptorsR M Kessler, M S Ansari, D E Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamidesR M Kessler, M S Ansari, T de Paulis, et al.
European Journal of Pharmacology|November 13, 1992
Visualization of extrastriatal dopamine D2 receptors in the human brainR M Kessler, N S Mason, J R Votaw, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
Brain Research|April 23, 1993
Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epideprideR M Kessler, W O Whetsell, M S Ansari, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
Particulate oral NMR contrast agentsV M Runge, M A Foster, J A Clanton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligandJ R Votaw, M S Ansari, N S Mason, et al.
Life Sciences|January 1, 1993
High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brainR M Kessler, J R Votaw, D E Schmidt, et al.
Pageof 5